Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency

Area of Science:

• Pulmonology
• Genetics
• Epidemiology

Background:

• Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder linked to early-onset chronic obstructive pulmonary disease (COPD).
• Significant variability exists in lung function impairment among individuals with the ZZ genotype of AATD.
• Early identification of high-risk individuals is crucial for proactive management of lung disease.

Purpose of the Study:

• To develop and validate prediction models for forced expiratory volume in 1 second (FEV1) and severe COPD in individuals with the ZZ genotype.
• To identify key demographic, clinical, and genetic factors influencing COPD progression in AATD patients.

Main Methods:

• A multicenter, family-based study utilized 372 participants with the ZZ genotype (2002-2005).
• Prediction models were developed using half the data and validated on the other half.
• Variables analyzed included demographic, clinical (e.g., smoking history, bronchodilator responsiveness), and genetic factors.

Main Results:

• Age, sex, smoking pack-years, bronchodilator responsiveness, chronic bronchitis symptoms, and index case status were predictive of FEV1 and severe COPD.
• The FEV1 prediction model explained 50% of the variance in the validation sample.
• The severe COPD prediction model demonstrated excellent discrimination (c-statistic = 0.88).

Conclusions:

• Predictive models can effectively identify individuals with ZZ genotype at risk for FEV1 decline and severe COPD.
• These models offer a valuable tool for personalized monitoring and treatment strategies in AATD management.
• Further research can refine these models for broader clinical application.